Valens SVP exercises options, sells 5,616 shares
Valens Semiconductor SVP of R&D Chairman David exercised stock options and sold the resulting shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Valens Semiconductor SVP of R&D Chairman David exercised stock options and sold the resulting shares. He exercised options for 5,616 Ordinary Shares at an exercise price of $0.86 per share, converting a derivative position into common equity.
On the same date, he sold 4,000 Ordinary Shares at $1.4634 per share and 1,616 Ordinary Shares at $1.4906 per share in open-market transactions. The filing notes these sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on August 16, 2024.
After the transactions, he held 403,968 Ordinary Shares directly, indicating he retained a substantial equity stake in Valens Semiconductor Ltd. while monetizing a relatively small portion of his holdings.
Insider Trade Summary 10b5-1
Exercise and Sale: 5,616 shares ($3K approx. pre-tax spread)
Exercise and Sale
4 txns
Insider
Chairman David
Role
SVP, R&D
Sold
5,616 shs ($8K)
Approx. gross sale proceeds
$8K
Approx. exercise cost
$5K
Approx. pre-tax spread
$3K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 5,616 | $0.00 | $0.00 |
| Exercise | Ordinary Shares | 5,616 | $0.86 | $5K |
| Sale | Ordinary Shares | 4,000 | $1.4634 | $6K |
| Sale | Ordinary Shares | 1,616 | $1.4906 | $2K |
Holdings After Transaction:
Stock Option (Right to Buy) — 94,079 contracts (Direct);
Ordinary Shares — 403,968 shares (Direct)
Footnotes (5)
- F1. The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024
- F2. The shares were acquired upon the exercise of stock options
- F3. The shares sold were acquired upon the exercise of stock options on the same date
- F4. The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.
- F5. The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.
Key Figures
Options exercised: 5,616 shares
Exercise price: $0.86 per share
Shares sold (first trade): 4,000 shares at $1.4634
+4 more
7 metrics
Options exercised
5,616 shares
Stock options exercised into Ordinary Shares
Exercise price
$0.86 per share
Exercise price of stock options
Shares sold (first trade)
4,000 shares at $1.4634
Open-market sale of Ordinary Shares
Shares sold (second trade)
1,616 shares at $1.4906
Open-market sale of Ordinary Shares
Shares held after transactions
403,968 shares
Direct ownership after exercise and sales
Option expiration
June 9, 2031
Original expiration date of exercised options
10b5-1 plan adoption date
August 16, 2024
Adoption date of trading plan governing sales
Key Terms
Rule 10b5-1 trading plan, stock options, Ordinary Shares, weighted average price, +1 more
5 terms
Rule 10b5-1 trading plan financial
"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
stock options financial
"The shares were acquired upon the exercise of stock options"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
weighted average price financial
"The price reported is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Valens Semiconductor (VLN) report for Chairman David?
Chairman David exercised options for 5,616 Ordinary Shares at $0.86 and sold 5,616 shares in open-market trades at weighted average prices of $1.4634 and $1.4906. These moves converted options into cash while maintaining a sizable remaining share position.
Were the Valens Semiconductor (VLN) insider sales under a Rule 10b5-1 plan?
Yes. The filing states the sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted on August 16, 2024. Such pre-arranged plans schedule trades in advance, making the timing more routine and less about short-term share price views.
What prices were involved in Chairman David’s Valens Semiconductor (VLN) transactions?
He exercised stock options at an exercise price of $0.86 per share and sold 4,000 shares at $1.4634 and 1,616 shares at $1.4906. The filing notes the reported sale prices are weighted averages across multiple executions.
Does the Valens Semiconductor (VLN) Form 4 show an options exercise-and-sell pattern?
Yes. The options were exercised for 5,616 Ordinary Shares and the same number of shares was sold the same day. Footnotes confirm the shares sold were acquired through option exercise, reflecting an exercise-and-sell liquidity event rather than a new open-market purchase.
Did Chairman David retain a significant stake in Valens Semiconductor (VLN) after selling shares?
Yes. Following the transactions, he still directly owns 403,968 Ordinary Shares. This indicates the reported sales represent only a small fraction of his overall holdings and that he continues to have substantial exposure to the company’s equity.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates